On April 18th, 2009, this site had posted the blog, "Strike 3 for Stryker!" Earlier that week Michael Sullivan, the U.S. Attorney for the DOJ announced a guilty plea to felony misbranding of OP-1 by a Stryker territory manager. At that time the question was asked whether Stryker was feeling the need to accelerate a return on their investment after spending hundreds of millions to the rights and subsequent ownership of OP-1? TSB wondered who is the Captain of the Ship?
As the saga of OP-1 continues, no less inspired by Stryker's need to grab a piece of that $1 billion dollar market that INFUSE plays in, with more and more hospitals evaluating the cost of that product, it is difficult to believe that a renegade group existed at Biotech without anyone knowing what was going on. What if Stryker was really teaching their reps on how to mix a cocktail of OP-1 and Calstrux? Does anyone believe that this was going on at an organization that is known for micro-management, without someone higher up not knowing ?
It will be interesting to see how this plays out, considering that if the defendants are convicted on all counts, they will spend a minimum of 16 years of prison. That is a mandatory 80% of a 20 year sentence. If I'm in their shoes, I believe its time to start naming names, and singing like a canary. You know what Robert Zimmerman use to sing; "It's a hard rain gonna fall!" TSB wants to know what its readers think?